These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12031282)

  • 1. Models of repair mechanisms for future treatment modalities of Parkinson's disease.
    Isacson O
    Brain Res Bull; 2002 Apr; 57(6):839-46. PubMed ID: 12031282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells in the treatment of Parkinson's disease.
    Arenas E
    Brain Res Bull; 2002 Apr; 57(6):795-808. PubMed ID: 12031276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair.
    Blesch A; Lu P; Tuszynski MH
    Brain Res Bull; 2002 Apr; 57(6):833-8. PubMed ID: 12031281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine and adult neurogenesis.
    Borta A; Höglinger GU
    J Neurochem; 2007 Feb; 100(3):587-95. PubMed ID: 17101030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurological disorders and neural regeneration: special reference to Parkinson's disease and cerebral ischemia].
    Date I
    Nihon Ronen Igakkai Zasshi; 2007 Jan; 44(1):72-5. PubMed ID: 17337856
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell transplantation for Parkinson's disease: present status.
    Drucker-Colín R; Verdugo-Díaz L
    Cell Mol Neurobiol; 2004 Jun; 24(3):301-16. PubMed ID: 15206816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.
    Björklund LM; Isacson O
    Prog Brain Res; 2002; 138():411-20. PubMed ID: 12432781
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurotrophic support of midbrain dopaminergic neurons.
    von Bohlen und Halbach O; Unsicker K
    Adv Exp Med Biol; 2009; 651():73-80. PubMed ID: 19731552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.
    Meyer M; Matarredona ER; Seiler RW; Zimmer J; Widmer HR
    Neuroscience; 2001; 108(2):273-84. PubMed ID: 11734360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic approaches to Parkinson's disease including neural transplants.
    Kuan WL; Barker RA
    Neurorehabil Neural Repair; 2005 Sep; 19(3):155-81. PubMed ID: 16093408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rewiring the brain with cell transplantation in Parkinson's disease.
    Gaillard A; Jaber M
    Trends Neurosci; 2011 Mar; 34(3):124-33. PubMed ID: 21316770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future of cell and gene therapies for Parkinson's disease.
    Isacson O; Kordower JH
    Ann Neurol; 2008 Dec; 64 Suppl 2(0 2):S122-38. PubMed ID: 19127583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomedicine. Combating Parkinson's disease--step three.
    Olson L
    Science; 2000 Oct; 290(5492):721-4. PubMed ID: 11184202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
    Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
    J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease.
    Burnstein RM; Foltynie T; He X; Menon DK; Svendsen CN; Caldwell MA
    Int J Biochem Cell Biol; 2004 Apr; 36(4):702-13. PubMed ID: 15010333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic directions for Parkinson's disease.
    Fisher LJ; Gage FH
    Mol Med Today; 1995 Jul; 1(4):181-7. PubMed ID: 9415155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.